Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2001;15(2):64-70.
doi: 10.1002/jcla.3.

Effect of substrate size on immunoinhibition of amylase activity

Affiliations

Effect of substrate size on immunoinhibition of amylase activity

I Warshawsky et al. J Clin Lab Anal. 2001.

Abstract

Immunoinhibition assays are hypothesized to work by antibodies blocking substrate access to enzyme active sites. To test this hypothesis, the inhibition of amylase isoenzymes by monoclonal and polyclonal antisera was assessed using substrates of varying sizes: chromogenic sustrates 3, 5, or 7 glucose units in length, novel synthetic macromolecular substrates, and starch. The synthetic macromolecular substrates consisted of small oligosaccharide substrates linked to an inert polymer that conferred a large size to substrate molecules as determined by gel filtration chromatography. When substrate size increased, amylase activity could be inhibited equivalently by antibody concentrations that are 10-fold lower. Progressively less polyclonal serum was required to inhibit amylase activity as substrate length increased from 3 to 5 to 7 glucose units and as size was increased by linkage to a polymer. Different effects of substrate size were observed with two monoclonal antibodies. One monoclonal antibody blocked amylase activity independent of substrate size, while another monoclonal antibody had little inhibitory effect except using starch as substrate. We conclude that use of larger substrates can expand the repertoire of inhibitory epitopes on enzymes and convert a noninhibitory antibody into an inhibitory one.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Rubenstein KE, Schneider RS, Ullman EF. 1972. “Homogeneous” enzyme immunoassay: new immunochemical technique. Biochem Biophys Res Commun 47:846–851. - PubMed
    1. Cinader B. 1965. In: Proceedings of the second meeting of the Foundation of European Biochemical Societies. Vienna: Oxford Pergamon; Vol 1 p 85–90.
    1. Gibbons I, Skold C, Rowley GL, Ullman EF. 1980. Homogenous enzyme immunoassay for proteins employing &bgr;‐galactosidase. Anal Biochem 102:167–170. - PubMed
    1. Skold C, Gibbons I, Russel ME, Juaristi E, Rowley GL, Ullman EF. 1985. Action of &bgr;‐galactosidase on novel synthetic macromolecular substrates. A processive enzymic reaction controlled by coulombic interactions. Biochim Biophys Acta 830:64–70. - PubMed
    1. Rowley GL, Rubenstein KE, Huisjen J, Ullman EF. 1975. Mechanism by which antibodies inhibit hapten‐malate dehydrogenase conjugates. J Biol Chem 250:3759–3766. - PubMed

MeSH terms

LinkOut - more resources